Clinical Study of CDP870/Certolizumab Pegol in Patients With Active Crohn's Disease

Clinical trial NCT00291668 · COMPLETED

Trial details

NCT number: NCT00291668
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2006-03-02
Primary completion: 2007-11-08
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.